Sort
8,912 grants matching “sars cov 2”
CODA: COvid and Diabetes Assessment
$241,579Russell L. Rothman · Vanderbilt University Medical Center · U01 · FY2024 · DK
Large-scale compatibility assessments between ACE2 proteins and diverse sarbecovirus spikes
$241,500Kenneth A Matreyek · Case Western Reserve University · R21 · FY2023 · AI
PET imaging of viral infection
$241,500Zhenghong Lee · Case Western Reserve University · R21 · FY2022 · AI
Host-microbe interactions and SARS-CoV-2 susceptibility and symptoms in a novel human challenge model
$241,500Matthew Scott Kelly · Duke University · R21 · FY2023 · AI
Global Network for Women's and Children's Health Research Data Coordinating Center
$241,469Elizabeth M McClure · Research Triangle Institute · U24 · FY2021 · HD
Rat Resource and Research Center
$241,421Elizabeth C Bryda · University Of Missouri-Columbia · P40 · FY2022 · OD
Development of a screening diagnostic for the detection of viruses and bacteria from body fluids that utilizes the unparalleled structural characterization of mass spectrometry
$241,356Aaron Timperman · University Of Pennsylvania · R21 · FY2023 · AI
Cognitive and Emotional Resilience to the COVID-19 pandemic among older adults at risk for Alzheimer's disease
$241,129Sofiya Milman · Albert Einstein College Of Medicine · R01 · FY2021 · AG
Administrative Supplement to R21: Mechanism and in vivo activity of novel glycan-based therapy against flavivirus endothelial permeability and vascular leak
$241,096Eva Harris · University Of California Berkeley · R21 · FY2020 · AI
Functionalized lipid inactosomes to bind and clear SARS-CoV-2
$240,984Daniel A Hammer · University Of Pennsylvania · R21 · FY2022 · AI
Vitamin D fluctuations and the mucosal immune response
$240,750Margherita T Cantorna · Pennsylvania State University, The · R01 · FY2020 · AT
Contribution of adipose tissue immune cells to Influenza pathogenesis
$240,750Senad Divanovic · Cincinnati Childrens Hosp Med Ctr · R21 · FY2025 · AI
Mechanisms of exacerbation of COVID-19 pathogenesis in mice expressing human ACE2 by polycyclic aromatic hydrocarbons (PAHs), and its protection by inhibition of soluble epoxide hydrolase (sEH)
$240,720Bhagavatula Moorthy · Baylor College Of Medicine · R21 · FY2021 · ES
Validation of a naturally-occurring animal model for SARS-CoV-2 infection
$240,655Craig Andrew Miller · Oklahoma State University Stillwater · P20 · FY2021 · GM
A COVID-19 Point of Care Serological Assay for Rapid Quantification of Antibody Titer.
$240,405Alberto Gandini · Accel Diagnostics, Llc · R44 · FY2021 · AI
Project-001
$240,377Donna L Farber · Columbia University Health Sciences · U19 · FY2025 · AI
Predicting the developmental trajectories of cognitive and motor dimensions from preterm neonatal vocalizations
$240,336Noboru Hiroi · University Of Texas Hlth Science Center · R21 · FY2021 · HD
Vaccine Response and Immunotherapeutics SWG
$240,263Anna Palmer Durbin · Johns Hopkins University · P30 · FY2023 · AI
NBER Center for Aging and Health Research - Au Suppl -- Framingham Heart Study
$240,208Anne Case · National Bureau Of Economic Research · P30 · FY2022 · AG
Mass gatherings as natural experiments: travel pulses reveal determinants of SARS-CoV-2 epidemic synchrony and predictability in U.S. states and counties
$240,096Pejman Rohani · University Of Georgia · R21 · FY2022 · AI
Molecular principles of anti-COVID-19 drug uptake by human nucleoside transporters
$240,020Seok-Yong Lee · Duke University · R21 · FY2022 · AI
tRNA-derived RNA Fragments and their Role in Nasal SARS-CoV-2 Infection
$240,000Xiaoyong Bao · University Of Texas Med Br Galveston · R21 · FY2023 · AI
Role of Hypoxia-Inducible Factors (HIFs) in Respiratory Syncytial Virus Infection
$240,000Antonella Casola · University Of Texas Med Br Galveston · R21 · FY2023 · AI
Utilizing a novel hamster model to determine neurologic and behavioral abnormalities of offspring from mothers infected with SARS-CoV-2
$240,000Kenneth Steven Plante · University Of Texas Med Br Galveston · R21 · FY2025 · NS
Therapeutic efficacy of favipiravir against henipavirus infections
$240,000Alexander Niclas Freiberg · University Of Texas Med Br Galveston · R21 · FY2021 · AI